| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.00014 | 1 |